<font color="red">Sedation_1</font> during endoscopic retrograde cholangiopancreatography : a randomized controlled study of <font color="red">patient_1</font> <font color="red">-_1</font> <font color="red">controlled_1</font> <font color="red">propofol_2</font> <font color="red">sedation_2</font> and that <font color="red">given_1</font> <font color="red">by_1</font> <font color="red">a_1</font> <font color="red">nurse_1</font> <font color="red">anesthetist_1</font> <font color="red">._1</font> 
<br>
<br> OBJECTIVE Different regimens are used for sedation during endoscopic retrograde cholangiopancreatography ( ERCP ) . Our objectives were to compare safety , ease of treatment , recovery , and patients ' experiences using <font color="red">patient_1</font> <font color="red">-_1</font> <font color="red">controlled_1</font> <font color="red">sedation_2</font> <font color="red">(_1</font> <font color="red">PCS_1</font> <font color="red">)_1</font> <font color="red">with_1</font> <font color="red">propofol_2</font> <font color="red">,_2</font> <font color="red">nurse_1</font> <font color="red">anesthetist_1</font> <font color="red">-_1</font> <font color="red">controlled_1</font> <font color="red">sedation_2</font> <font color="red">(_1</font> <font color="red">ACS_1</font> <font color="red">)_1</font> <font color="red">,_1</font> or the department 's standard of care , <font color="red">midazolam_2</font> given by the procedure team ( control group ) . 
<br> MATERIAL AND METHODS The study included 281 adults in 301 procedures . The PCS group ( n = 101 ) delivered bolus doses of 5 mg of <font color="red">propofol_1</font> according to their need for <font color="red">sedation_1</font> <font color="red">._1</font> The ACS group ( n = 100 ) had 2 - 8 mg / kg / h of <font color="red">propofol_1</font> infused , with the target for <font color="red">sedation_1</font> being level 3 of the Observer 's Assessment of Alertness / Sedation ( OAA / S ) scale . The control group was given 2 - 3 mg of <font color="red">midazolam_1</font> for induction and additional 1 mg if required . 
<br> RESULTS <font color="red">PCS_1</font> and <font color="red">ACS_1</font> increased the ease of the procedure and reduced the number of <font color="red">sedation_1</font> failures compared to <font color="red">midazolam_2</font> <font color="red">sedation_2</font> ( <font color="red">ACS_1</font> n = 0 ; <font color="red">PCS_1</font> n = 4 ; <font color="red">midazolam_2</font> n = 20 ) . The ACS group had more deeply sedated patients ( OAA / S level 2 ) , desaturation , and obstructed airways than the PCS and <font color="red">midazolam_1</font> groups . Time to full recovery ( Aldrete score â‰¥9 ) was shortest following <font color="red">PCS_1</font> <font color="red">._1</font> <font color="red">PCS_1</font> resulted in the least fatigue and pain after the procedure . Patients ' preference for <font color="red">PCS_1</font> and <font color="red">ACS_1</font> was the same . 
<br> CONCLUSION <font color="red">PCS_1</font> <font color="red">with_1</font> <font color="red">propofol_2</font> is superior to <font color="red">midazolam_2</font> and comparable to <font color="red">ACS_1</font> <font color="red">._1</font> <font color="red">PCS_1</font> resulted in a rapid recovery , fewer respiratory events , and was almost as effective as <font color="red">ACS_1</font> in ensuring a successful examination .